Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Oppenheimer Asset Management Inc.

Posted by on May 6th, 2023

Oppenheimer Asset Management Inc. reduced its stake in shares of Azenta, Inc. (NASDAQ:AZTA – Get Rating) by 61.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,751 shares of the company’s stock after selling 27,150 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Azenta were worth $975,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in AZTA. Macquarie Group Ltd. purchased a new stake in shares of Azenta during the 2nd quarter worth $160,068,000. State Street Corp purchased a new stake in shares of Azenta during the 2nd quarter worth $141,290,000. Brown Advisory Inc. boosted its position in shares of Azenta by 227.9% during the 3rd quarter. Brown Advisory Inc. now owns 1,693,994 shares of the company’s stock worth $72,606,000 after purchasing an additional 1,177,443 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Azenta by 76.8% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,218,034 shares of the company’s stock worth $95,063,000 after purchasing an additional 963,811 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD purchased a new stake in shares of Azenta during the 2nd quarter worth $46,502,000. 96.42% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on AZTA shares. Needham & Company LLC reiterated a “buy” rating and issued a $68.00 price objective on shares of Azenta in a research report on Tuesday, April 18th. B. Riley decreased their price objective on shares of Azenta from $77.00 to $68.00 and set a “buy” rating on the stock in a research report on Friday, February 10th. Finally, Stephens lowered shares of Azenta from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $65.00 to $60.00 in a research report on Thursday, February 9th. One investment analyst has rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Azenta presently has a consensus rating of “Moderate Buy” and a consensus target price of $66.80.

Azenta Trading Up 2.8 %

Shares of AZTA stock opened at $45.59 on Friday. The firm has a 50-day moving average price of $42.98 and a 200 day moving average price of $50.05. Azenta, Inc. has a twelve month low of $37.61 and a twelve month high of $78.82. The company has a market capitalization of $3.15 billion, a price-to-earnings ratio of 1.65 and a beta of 1.58.

Azenta (NASDAQ:AZTA – Get Rating) last announced its earnings results on Wednesday, February 8th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.05 by $0.07. Azenta had a net margin of 349.08% and a return on equity of 1.17%. The firm had revenue of $178.00 million during the quarter, compared to the consensus estimate of $181.38 million. During the same quarter in the previous year, the company posted $0.12 EPS. The firm’s revenue for the quarter was up 27.1% on a year-over-year basis. As a group, research analysts predict that Azenta, Inc. will post 0.28 earnings per share for the current year.

Azenta Profile

(Get Rating)

Azenta, Inc is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples.

Featured Articles

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.